期刊文献+

腹膜透析患者发生肺动脉高压危险因素分析 被引量:2

The risk factors for pulmonary hypertension in peritoneal dialysis patients
下载PDF
导出
摘要 目的探讨腹膜透析(peritoneal dialysis,PD)患者肺动脉高压(pulmonary hypertension,PH)的发生率及其危险因素。方法采取回顾性收集109例PD患者的临床资料、检验指标及心脏彩超结构,使用组问比较、单因素及多因素logistics回归分析探讨肺动脉收缩压(pulmonary artery systolic pressure,PASP)的影响因素。结果 109例患者中PH占50例(45.87%),PH组血浆白蛋白(albumin,ALB)、血红蛋白(hemoglobin,Hb)、左心室射血分数(left ventricular ejection fraction,LVEF)较非肺动脉高压组(no pulmonary hypertension,N-PH)组低(t=4.424,P<0.001;t=3.318,P=0.001;t=2.287,P=0.024);血清钙磷乘积值(t=-2.198,P=0.030)、左心房大小(left atrial diame ter,LA)(t=-3.961,P<0.001)、肺动脉主干(main pulmonary artery,MPA)(t=-2.878,P=0.005)、左心室收缩末期直径(left ventricular end systolic dimension,LVDs)(t=-3.438,P=0.001)、左心室舒张末期直径(left ventricular end diasrolic diameter,LVDd)(t=-2.662,P=0.009)、室间隔厚度(interventricular septal thickness,IVST)(t=-2.953,P=0.004)较N-PH组高。单因素回归分析结果显示,ALB(B=-0.206,P<0.001)、Hb(B=-0.033,P=0.002)、LVEF(B=-0.050,P=0.027)与PASP呈负相关;钙磷乘积(B=0.421,P=0.035)、LA(B=0.138,P=0.001)、LVDd(B=0.084,P=0.013)、LVDs(B=0.114,P=0.003)与PASP呈在正相关;多因素回归分析结果显示,ALB(OR=0.786,95%CI 0.690~0.896,P<0.001)、LA(OR=1.117,95%CI 1.019~1.224,P=0.018)、钙磷乘积(OR 2.509,95%CI 1.312~4.799,P=0.005)是PASP的独立危险因素。结论 PD患者中PH发生率较高,低白蛋白血症、左心房扩大、钙磷乘积增高为PH发生的独立危险因素。 Objective To analyze the risk factors and prevalence of pulmonary hypertension (PH) in peritoneal dialysis (PD) patients. Methods Clinical, laboratory and echocardiographic data from 109 PD patients were retrospectively analyzed. The risk factors for PH were investigated by comparison between groups. Logistic regression was used for the analyses. Results Fifty of the 109 patents (45.87%) had PH. Compared to the patients without PH, patients with PH had lower levels of plasma albumin (ALB) (t=4.424, P〈 0.001), hemoglobin (Hb) (t=3.318, P=-0.001) and left ventricular ejection fraction (LVEF) (t=-2.287, P= 0.024), and higher levels of calcium-phosphorus product (t=--2.198, P=-0.030), left atrial diameter (LA) (t=- 3.961, P〈0.001), main pulmonary artery (MPA) (t=-2.878, P=-0.005), left ventricular end-systolic diameter (LVDs) (t=-3.438, P=0.001), left ventricular end-diastolic diameter (LVDd) (t=-2.662,P=-0.009) and interven- tricular septal thickness (IVST) (t=--2.953, P=0.004). Univariate regression analyses showed that pulmonary artery systolic pressure (PASP) was negatively correlated with ALB (β=-0.206, P〈0.001), Hb (β=-0.033, P= 0.002) and LVEF (β=-0.050, P=-0.027), and was positively correlated with calcium-phosphorus product (β= 0.421, P=-0.035), LA (β=0.138, P=-0.001), LVDd (β=0.084, P=-0.013) and LVDs (β=0.114, P=-0.003 ). Multivariate regression analyses displayed that ALB (OR 0.786, 95% CI 0.690-0.896, P〈0.001), LA (OR 1.117, 95% CI 1.019-1.224, P=-0.018) and calcium-phosphorus product (OR 2.509, 95% CI 1.312-4.799, P= 0.005) were the independent risk factors for PASE Conclusions PH was relatively prevalent in PD patients. The decreased ALB and increased LA and calcium-phosphorus product were the independent risk factors for PH in PD patients.
出处 《中国血液净化》 2017年第4期234-237,共4页 Chinese Journal of Blood Purification
关键词 腹膜透析 肺动脉高压 危险因素 Peritoneal dialysis Pulmonary hypertension Influential factor
  • 相关文献

参考文献6

二级参考文献82

  • 1荆志成.2010年中国肺高血压诊治指南[J].中国医学前沿杂志(电子版),2011,3(2):62-81. 被引量:116
  • 2张薇,郑兆通,黎莉,钟明,朱清,张运.肺动脉高压左心室舒张功能障碍机制的研究[J].山东大学学报(医学版),2006,44(2):131-134. 被引量:12
  • 3Yigla M,Nakhoul F,Sabag A,et al.Pulmonary hypertension in patients with end-stage renal disease[J].Chest,2003,123(5): 1577-1582.
  • 4Havlucu Y,Kursat S,Ekmekci C,et al.Pulmonary hypertension in patients with chronic renal failure[J].Respiration,2007,74(5): 503-510.
  • 5Bozbas SS,Akcay S,Altin C,et al.Pulmonary hypertension in patients with end-stage renal disease undergoing renal transplantation [J].Transplant Proc,2009,41(7): 2753-2756.
  • 6Ramasubbu K,Deswal A,Herdejurgen C,et al.A prospective echocardiographic evaluation of pulmonary hypertension in chronic hemodialysis patients in the United States: prevalence and clinical significance[J].Int J Gen Med,2010,3: 279-286.
  • 7Abdelwhab S,Elshinnawy S.Pulmonary hypertension in chronic renal failure patients[J].Am J Nephrol,2008,28(6): 990-997.
  • 8Pabst S,Hammerstingl C,Hundt F,et al.Pulmonary hypertension in patients with chronic kidney disease on dialysis and without dialysis: result of the PEPPER-study[J].PLoS One,2012,7(4): e35310.
  • 9Yigla M,Fruchter O,Aharonson D,et al.Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients[J].Kidney Int,2009,75(9): 969-975.
  • 10Reisner SA,Azzam Z,Halmann M,et al.Septal/free wall curvature ratio: a noninvasive index of pulmonary arterial pressure[J].J Am Soc Echocardiogr,1994,7(1): 27-35.

共引文献25

同被引文献9

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部